donepezil has been researched along with Cacosmia in 2 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Donepezil was started at 5 mg daily, increased to 10 mg daily if tolerated, and then the dose was kept constant for 52 weeks." | 1.46 | Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment. ( Andrews, H; Bell, K; Chunga, RE; Ciarleglio, A; Devanand, DP; Huey, ED; Lentz, C; Pelton, GH; Schofield, PW; Scodes, JM; Stern, Y, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devanand, DP | 1 |
| Lentz, C | 1 |
| Chunga, RE | 1 |
| Ciarleglio, A | 1 |
| Scodes, JM | 1 |
| Andrews, H | 1 |
| Schofield, PW | 1 |
| Stern, Y | 1 |
| Huey, ED | 1 |
| Bell, K | 1 |
| Pelton, GH | 1 |
| Velayudhan, L | 1 |
| Lovestone, S | 1 |
1 trial available for donepezil and Cacosmia
| Article | Year |
|---|---|
Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Monitoring; F | 2009 |
1 other study available for donepezil and Cacosmia
| Article | Year |
|---|---|
Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
Topics: Aged; Atropine; Cholinesterase Inhibitors; Cognitive Dysfunction; Donepezil; Female; Humans; Indans; | 2017 |